Genetic Technologies Limited (GNTLF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 643.54 Thousand AUD | 64.25% |
| 2023 | 532.84 Thousand AUD | -18.34% |
| 2022 | 652.52 Thousand AUD | 219.81% |
| 2021 | 204.03 Thousand AUD | -57.65% |
| 2020 | 481.78 Thousand AUD | 0.0% |
| 2019 | - AUD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | -100.0% |
| 2015 | 25 Thousand AUD | -99.0% |
| 2014 | 2.5 Million AUD | 0.0% |
| 2013 | - AUD | -100.0% |
| 2012 | 17.74 Thousand AUD | -73.85% |
| 2011 | 67.87 Thousand AUD | -82.26% |
| 2010 | 382.64 Thousand AUD | -17.31% |
| 2009 | 462.72 Thousand AUD | 54.84% |
| 2008 | 298.83 Thousand AUD | -75.61% |
| 2007 | 1.22 Million AUD | -27.18% |
| 2006 | 1.68 Million AUD | 140.6% |
| 2005 | 699.35 Thousand AUD | 0.48% |
| 2004 | 696.04 Thousand AUD | 0.0% |
| 2003 | - AUD | 0.0% |
| 2002 | - AUD | -100.0% |
| 2001 | 120.08 Thousand AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 84.13 Thousand AUD | -84.21% |
| 2024 Q4 | 643.54 Thousand AUD | 0.0% |
| 2024 FY | 875.18 Thousand AUD | 64.25% |
| 2024 Q2 | 382.31 Thousand AUD | 354.4% |
| 2023 FY | 532.84 Thousand AUD | -18.34% |
| 2023 Q4 | 532.84 Thousand AUD | 132.4% |
| 2023 Q3 | 229.27 Thousand AUD | -62.56% |
| 2023 Q1 | 328.41 Thousand AUD | -49.67% |
| 2023 Q2 | 612.39 Thousand AUD | 86.47% |
| 2022 FY | 652.52 Thousand AUD | 219.81% |
| 2022 Q3 | 388.39 Thousand AUD | 242.24% |
| 2022 Q4 | 652.52 Thousand AUD | 68.01% |
| 2022 Q2 | 113.48 Thousand AUD | 238.66% |
| 2022 Q1 | 33.51 Thousand AUD | -83.58% |
| 2021 Q4 | 204.03 Thousand AUD | 735.81% |
| 2021 Q2 | 366.99 Thousand AUD | 215.2% |
| 2021 Q1 | 116.43 Thousand AUD | -75.83% |
| 2021 FY | 204.03 Thousand AUD | -57.65% |
| 2021 Q3 | 24.41 Thousand AUD | -93.35% |
| 2020 Q4 | 481.78 Thousand AUD | 100.02% |
| 2020 Q1 | 137.3 Thousand AUD | 0.0% |
| 2020 Q2 | 362.08 Thousand AUD | 163.71% |
| 2020 Q3 | 240.87 Thousand AUD | -33.48% |
| 2020 FY | 481.78 Thousand AUD | 0.0% |
| 2019 FY | - AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 Q1 | - AUD | 0.0% |
| 2019 Q3 | - AUD | 0.0% |
| 2019 Q4 | - AUD | 0.0% |
| 2018 Q1 | - AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2018 Q3 | - AUD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 Q3 | - AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 Q1 | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 Q3 | - AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 Q1 | - AUD | -100.0% |
| 2016 FY | - AUD | -100.0% |
| 2015 Q1 | 1.5 Million AUD | -40.06% |
| 2015 Q3 | 25 Thousand AUD | -98.33% |
| 2015 Q2 | 1.5 Million AUD | 0.0% |
| 2015 FY | 25 Thousand AUD | -99.0% |
| 2015 Q4 | 25 Thousand AUD | 0.0% |
| 2014 Q2 | 5.35 Million AUD | 0.0% |
| 2014 Q1 | 5.35 Million AUD | 0.0% |
| 2014 Q4 | 2.5 Million AUD | 0.0% |
| 2014 Q3 | 2.5 Million AUD | -53.25% |
| 2014 FY | 2.5 Million AUD | 0.0% |
| 2013 Q3 | - AUD | 0.0% |
| 2013 FY | - AUD | -100.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2012 Q2 | 43.4 Thousand AUD | 0.0% |
| 2012 FY | 17.74 Thousand AUD | -73.85% |
| 2012 Q4 | 17.74 Thousand AUD | 0.0% |
| 2011 FY | 67.87 Thousand AUD | -82.26% |
| 2011 Q4 | 67.87 Thousand AUD | 0.0% |
| 2011 Q2 | 262.64 Thousand AUD | 0.0% |
| 2010 Q2 | 497.43 Thousand AUD | 0.0% |
| 2010 FY | 382.64 Thousand AUD | -17.31% |
| 2010 Q4 | 382.64 Thousand AUD | 0.0% |
| 2009 FY | 462.72 Thousand AUD | 54.84% |
| 2009 Q2 | 446.45 Thousand AUD | 0.0% |
| 2009 Q4 | 373.44 Thousand AUD | 0.0% |
| 2008 FY | 298.83 Thousand AUD | -75.61% |
| 2008 Q2 | 233.22 Thousand AUD | 0.0% |
| 2008 Q4 | 298.83 Thousand AUD | 0.0% |
| 2007 FY | 1.22 Million AUD | -27.18% |
| 2007 Q4 | 1.22 Million AUD | 0.0% |
| 2007 Q2 | 779.91 Thousand AUD | 0.0% |
| 2006 FY | 1.68 Million AUD | 140.6% |
| 2006 Q4 | 1.68 Million AUD | 0.0% |
| 2006 Q2 | - AUD | 0.0% |
| 2005 Q2 | 700.22 Thousand AUD | 0.0% |
| 2005 Q4 | 699.35 Thousand AUD | 0.0% |
| 2005 FY | 699.35 Thousand AUD | 0.48% |
| 2004 FY | 696.04 Thousand AUD | 0.0% |
| 2003 FY | - AUD | 0.0% |
| 2002 FY | - AUD | -100.0% |
| 2001 FY | 120.08 Thousand AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.24 Million USD | 71.27% |
| Arrayit Corporation | 1.07 Million USD | 40.311% |
| Atlantic International Corp. | 2.93 Million USD | 78.04% |
| Biocept, Inc. | 12.1 Million USD | 94.685% |
| Bioqual, Inc. | 3.58 Million USD | 82.059% |
| CardioGenics Holdings Inc | 72.61 Thousand USD | -786.256% |
| DermTech, Inc. | 54.39 Million USD | 98.817% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 99.864% |
| HTG Molecular Diagnostics, Inc. | 4.83 Million USD | 86.687% |
| iMD Companies, Inc. | 1.12 Million USD | 42.548% |
| IDenta Corp. | 789.14 Thousand USD | 18.45% |
| Interpace Biosciences, Inc. | 11.19 Million USD | 94.25% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 43.84 Thousand USD | -1367.775% |
| Lumos Diagnostics Holdings Limited | 8.04 Million USD | 92.001% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 3.82 Million USD | 83.179% |
| NovelStem International Corp. | 3.57 Million USD | 81.997% |
| Optigenex Inc. | 8.94 Million USD | 92.802% |
| PharmChem, Inc. | 77.35 Thousand USD | -731.96% |
| Proteome Sciences plc | 17.15 Million USD | 96.248% |
| Response Genetics, Inc | 6.37 Million USD | 89.902% |
| Rennova Health, Inc. | 15.32 Million USD | 95.802% |
| RushNet, Inc. | 4.82 Million USD | 86.657% |
| ScreenPro Security Inc. | 207.03 Thousand USD | -210.841% |
| Stella Diagnostics Inc. | 6.2 Million USD | 89.621% |
| StageZero Life Sciences Ltd. | 1.8 Million USD | 64.249% |
| Todos Medical Ltd. | 38.34 Million USD | 98.322% |